文献速递肝胆胰外科围术期管理与 ERAS

单中心500例胰十二指肠切除术:达芬奇Xi机器人对比开腹的病例匹配结局

Single-institution experience of 500 consecutive pancreatoduodenectomies: case-matched outcomes of the da Vinci Xi robotic versus open procedures.
PubMed 文献 · Surg Endosc · 2026-04-13

本研究在单中心比较了112例机器人胰十二指肠切除术(R-PD)与1:1匹配的112例开腹手术(O-PD)的结局。R-PD组临床相关胰瘘和胃排空延迟发生率更低,住院时间更短,而主要并发症和死亡率无差异。在具备机器人及胰腺专业经验的高容量中心,R-PD可作为安全替代方案。

要点

  • R-PD组临床相关胰瘘发生率5.4%,低于O-PD组的14.3%(p=0.025)。
  • R-PD组临床相关胃排空延迟发生率21.4%,低于O-PD组的37.5%(p=0.008)。
  • R-PD组中位住院时间11天,短于O-PD组的19.5天(p<0.001)。

核心结论

  • 在具备机器人及胰腺专业经验的高容量中心,R-PD是安全替代方案,中转率极低,围术期恢复可能更优。
  • R-PD可能作为经过适当选择患者的一线选择。

研究设计与样本

  • 112例R-PD与112例O-PD按患者相关手术风险、疾病相关因素和术者经验进行1:1病例匹配。
  • 采用单变量和多变量逻辑回归分析临床相关POPF和DGE的预测因素。

主要发现

  • 平均手术时间两组相当(389 vs 399 min,p=0.315),R-PD无中转开腹。
  • 临床相关POPF发生率R-PD 5.4% vs O-PD 14.3%(p=0.025)。
  • 临床相关DGE发生率R-PD 21.4% vs O-PD 37.5%(p=0.008)。
  • 中位住院时间R-PD 11(8-22.75)天 vs O-PD 19.5(13-27.5)天(p<0.001)。

关键数值与推荐

  • 回归分析显示机器人入路在单变量分析中与较低的临床相关POPF风险相关,在多变量分析中与较低的临床相关DGE风险相关。

临床怎么用

  • 在经验丰富的高容量中心,R-PD可考虑作为适当选择患者的一线术式。
  • 机器人入路可能降低临床相关POPF和DGE风险,并缩短住院时间。

局限性

  • 单中心回顾性研究,R-PD病例自2018年起,可能存在时间偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatoduodenectomy (PD) remains a technically demanding procedure with substantial postoperative morbidity. The robotic PD (R-PD) may offer advantages over open PD (O-PD), but its role is still under scrutiny. This study compared R-PD and O-PD within a mature, high-volume single-institution experience. METHODS: From October 2008 to May 2024, 500 PDs were performed at our institution (388 O-PDs and 112 R-PDs since January 2018). The 112 R-PD cases were 1:1 case-matched with 112 O-PD cases to ensure comparability in terms of patient-related surgical risk (sex, age, BMI, ASA score), disease-related factors (histological diagnosis, and T stage) and surgeon-related expertise. Univariable and multivariable logistic regression analyses were performed to identify predictors of clinically relevant postoperative pancreatic fistula (POPF) and delayed gastric emptying (DGE). RESULTS: Mean operative time was comparable between groups (389 vs 399 min, p = 0.315), with no conversions to open surgery for R-PD. Clinically relevant POPF occurred in 5.4% of R-PD patients vs 14.3% of O-PD (p = 0.025), and clinically relevant DGE in 21.4% vs 37.5% (p = 0.008). Median length of stay was shorter after R-PD (11 [8-22.75] vs 19.5 [13-27.5] days, p < 0.001). Rates of major complications (Clavien-Dindo ≥ III) were similar (15.2% for R-PD vs 14.3% for O-PD, p = 0.850). Thirty-day mortality was comparable (0.9% vs 1.8%, p = 0.561), while ninety-day mortality was 2.7% in both groups. Regression analysis showed that the robotic approach was associated with a lower risk of clinically relevant POPF in univariable analysis and a reduced risk of clinically relevant DGE in multivariable analysis. CONCLUSIONS: When performed in centers with established robotic and pancreatic expertise, R-PD appears to be a safe alternative to open surgery, with an extremely low risk of conversion and potential advantages in perioperative recovery. These findings suggest that R-PD may be considered a first-line option in appropriately selected patients within experienced high-volume programs.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Morelli L, Furbetta N, Guadagni S, et al. Single-institution experience of 500 consecutive pancreatoduodenectomies: case-matched outcomes of the da Vinci Xi robotic versus open procedures. Surg Endosc. 2026. PMID: 42301454. doi:10.1007/s00464-026-12807-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。